Tumor Markers 2019: Supplier Country Shares and Strategic Assessments of Major Players

Tumor Markers 2019: Supplier Country Shares and Strategic Assessments of Major Players

  • May 2019 •
  • 80 pages •
  • Report ID: 5298268 •
  • Format: PDF
Tumor Markers 2019: Supplier Country Shares and Strategic Assessments of Major Players

This new 80-page report provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.

The assessments include:

  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages


Companies Profiled
Company Assessments

- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Clinical Genomics
- Decode Genetics
- DiaSorin
- Diazyme
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic
- Janssen Diagnostics
- Kyowa Medex
- Leica Biosystems
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- PerkinElmer
- Polymedco
- Qiagen
- Quest Diagnostics
- Roche
- Scienion
- Sequenom
- Siemens Healthineers
- Takara Bio
- Theradiag
- Thermo Fisher
- Tosoh
- Vermillion
- Wako Pure Chemicals